Valuation : Astal Laboratories Limited

Market Cap 2.76B 29.22M 25.15M 23.66M 21.61M 40.43M 40.54M 280M 108M 1.42B 110M 107M 4.56B P/E 2024
26.3x
P/E 2025 9.45x
Enterprise Value 2.87B 30.45M 26.2M 24.65M 22.52M 42.12M 42.24M 291M 113M 1.47B 114M 112M 4.75B EV / Sales 2024
1.45x
EV / Sales 2025 1.36x
Free-Float
41.06%
Yield 2024 *
-
Yield 2025 -
1 day-3.20%
1 week-2.34%
Current month-4.32%
1 month-7.32%
3 months+12.99%
6 months+8.39%
Current year-11.46%
1 week 74.05
Extreme 74.05
81
1 month 74.05
Extreme 74.05
89.5
Current year 60.45
Extreme 60.45
91.9
1 year 60.45
Extreme 60.45
103.2
3 years 32.05
Extreme 32.05
131.7
5 years 5.41
Extreme 5.41
131.7
10 years 5.41
Extreme 5.41
131.7
Manager TitleAgeSince
Director of Finance/CFO 51 14/07/2023
Compliance Officer 32 18/04/2023
Director TitleAgeSince
Director/Board Member - 07/09/2022
Director/Board Member - 07/09/2022
Director/Board Member - 07/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
-3.20%-2.34%-7.88%+139.94% 36.81M
-0.88%-2.15%+54.71%+106.31% 1,034B
-1.15%+2.68%+53.97%+71.50% 671B
-1.44%+0.38%+20.40%+73.05% 460B
+0.14%-0.47%+29.49%+38.56% 353B
-1.33%+4.72%+24.69%+45.55% 309B
-1.15%+0.30%-1.49%+12.31% 255B
-1.55%+1.11%+56.10%+70.32% 240B
-0.88%+1.15%-17.09%-54.39% 207B
-0.15%+3.65%+33.90%+96.99% 188B
Average -1.21%+0.84%+24.68%+60.01% 371.68B
Weighted average by Cap. -1.10%+0.51%+36.61%+66.21%

Financials

2024 2025
Net sales 237M 2.51M 2.16M 2.03M 1.85M 3.47M 3.48M 23.98M 9.3M 121M 9.41M 9.21M 391M 637M 6.74M 5.8M 5.46M 4.99M 9.33M 9.35M 64.5M 25.03M 327M 25.32M 24.76M 1.05B
Net income 7.85M 83.11K 71.52K 67.29K 61.47K 115K 115K 795K 309K 4.03M 312K 305K 12.97M 89.25M 945K 813K 765K 699K 1.31M 1.31M 9.04M 3.51M 45.79M 3.55M 3.47M 148M
Net Debt -57.64M -611K -525K -494K -452K -845K -847K -5.84M -2.27M -29.57M -2.29M -2.24M -95.28M 115M 1.22M 1.05M 989K 904K 1.69M 1.7M 11.69M 4.54M 59.2M 4.59M 4.49M 191M
Logo Astal Laboratories Limited
Astal Laboratories Limited is an India-based company, which is engaged in the manufacturing and sale of pharmaceutical intermediates and bulk drugs. The Company is engaged in manufacturing fine chemicals, specialty chemicals and pharmaceutical intermediates. The Company’s products include HF Acid (2-Chloro-1,3-Bis (Dimethylamino) Trimethinium Hexafluorophosphate); 4-Methyl Sulphonyl Phenyl Acetic acid, (1R,3R)-methyl 1-(benzo[d][1,3] dioxol-5-yl)- 2,3,4,9-tetrahydro-1 H-pyrido[3,4-b]indole-3- carboxylate hydrochloride; L-Valine methyl ester Hydrochloride (LVMH); L-Valine benzyl ester Hydrochloride; N-[(2-Cyanobiphenyl-4-methyl)- L-Valine methyl ester Hydrochloride; D-Tryptophan Methyl Ester Hydrochloride; Moc-L-valine (N-(Methoxycarbonyl)-L-valine); 2-Ethoxyethyl-4-methylbenzene sulfonate; 2 Piperidin-4-yl-1H-benzoimidazole; Alpha, alpha-Dimethyl Phenyl Acetic Acid (2-Methyl-2-phenylpropionic acid); 2-(4-bromophenyl)-2-methylpropionic acid; Methyl 2,2-dimethylphenylacetate, and others.
Employees
-
Date Price Change Volume
04/09/26 ₹76.90 -3.20% 33,026
03/09/26 ₹79.44 +1.37% 39,069
02/09/26 ₹78.37 +0.62% 22,998
01/09/26 ₹77.89 -3.09% 21,825
31/08/26 ₹80.37 +2.07% 13,076
  1. Stock Market
  2. Stocks
  3. 512600 Stock